Peptides & Advanced Therapies sourcing for licensed providers.

A broad specialty portfolio spanning recovery, body composition, mitochondrial, longevity, and related categories. Every item is qualified for classification and permitted commercial pathway before it is quoted, and compounded, commercially manufactured, specialty, and research material are maintained in distinct sourcing pathways.

Dosage forms & formats

  • Lyophilized vials
  • Compounded combination formulations
  • Subcutaneous and intramuscular presentations

Built for

Longevity and performance clinics, sports medicine and recovery practices, regenerative medicine groups, and integrative providers building protocol driven programs.

Portfolio depth

26

Named products and formulations in this pathway, with more available on request.

Peptides & Advanced Therapies portfolio

Compounded, commercially manufactured, specialty, and research products are maintained in distinct sourcing pathways. Plativia confirms classification before any transaction.

  • BPC-157
  • BPC-157 + TB-500
  • BPC-157 + KPV + TB-500
  • BPC-157 + TB-500 + GHK-Cu
  • BPC-157 + GHK-Cu + KPV + TB-500
  • TB-500
  • CJC-1295 + Ipamorelin
  • Sermorelin
  • Sermorelin + Ipamorelin
  • Tesamorelin
  • Tesamorelin + Ipamorelin
  • MOTS-C
  • MOTS-C + Tesamorelin
  • SS-31
  • Thymosin Alpha-1
  • GHK-Cu
  • KPV
  • LL-37
  • IGF-LR3
  • Gonadorelin
  • Kisspeptin
  • Epitalon / Epithalon
  • Semax + Selank
  • DSIP
  • PT-141 / Bremelanotide
  • Pinealon + PE-22-28 + Selank
  • Not listed?Custom sourcing requests for this pathway are reviewed case by case.Ask us

Get pricing on peptides & advanced therapies

Send your states, volume, and the formulations you run. We confirm availability and the sourcing pathway, then return pricing and a fulfillment plan.

Request pricing

Qualification

Compounded, commercially manufactured, specialty, and research products are maintained in distinct sourcing pathways. Plativia confirms classification before any transaction.

Product and service availability is subject to qualification, applicable law, pharmacy and supplier capability, state eligibility, clinical pathway, and final contracting. Portfolio inclusion does not imply universal availability or suitability, and nothing here constitutes medical advice or a representation that every listed product is available for every use.